Brainomix Company
Brainomix has developed automated medical software for stroke image analysis, and lung diseases such as NSCLC and IPF. Our Radiology AI biomarkers enable precision medicine for better treatment.
Investors
%20.jpg)
Total Funding:
35017490
Headquarters:
Oxford, Oxfordshire, United Kingdom
Funding Status:
Early Stage Venture
Employee Number:
9
Estimated Revenue:
$33.16M
Last Funding Type:
Series B
Number Of Exists:
11-50
Last Funding Date:
2021-12-16
Investors Number:
6
Founded Date:
2010-01-01
Industry:
Aging Biomarkers